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A second type of TCR composed of a y gene product and a putative S gene
product has been identified on subpopulations of human and murine thymocytes
(1, 2), human lymphocytes (3-5), and murine Thy-I + skin cells (6, 7). Although
some TCR-y/6-expressing cells can exert NK cell activity in vitro (3-5) that can
be blocked by anti-T3 (3-5) and antiidiotypic reagents (5), the ligand and the
physiological role for the TCR-y/b remains unclear.
It is important to gain insight into the diversity of the TCR-y/b to define its
recognitive potential. The y chain gene family is known to encode four C regions
(1 pseudogene) and seven V regions which can give rise to at least five y chain
mRNA transcripts (8-13) . It is unknown if all these transcripts give rise to cell
surface-expressed proteins. Recently, a possible candidate for the b gene family
has been identified (14), but little data exist concerning the diversity of the
expressed protein. To investigate the diversity of TCR-y/b at the protein level,
we compared TCR-y/b from a panel of six murine hybridomas, two derived
from C3H/HeN Thy-I''- dendritic epidermal cells (15) and four from C57BL/6
thymocytes (16).
Materials and Methods
Cell Lines.
￿
T cell hybridomas expressing TCR-y/b were made by fusion of C3H/HeN-
derived Thy-I + dendritic epidermal cell lines (15) or cultured C57BL/6-derived Lyt-
2- ,L3T4- thymocytes (16) with the BW5147 fusion partner as described previously (15,
16). These hybridomas express the CD3-associated TCR-y/b (15, 16).
Immunoprecipitation, SDS-PAGE, and NEPHGE-analysis. Immunoprecipitations were
carried out using the anti-T3 mAb 2C I1 (17) and "5I-labeled digitonin lysates of TCR-
-y/b expressing hybridomas as described previously (6). Immunoprecipitates were either
analyzed on 12% SDS-PAGE gels or on two-dimensional NEPHGE/SDS-PAGE gels. For
NEPHGE (18), the immunoprecipitates were resuspended in 50 A.1 sample buffer (9 M
urea, 2% NP-40, 2% ampholines, pH 3 .5-10 [LKB, Gaithersburg, MD], 5% 2-Mercap-
toethanol) and applied to 12-cm NEPHGE cylindrical gels (4% acrylamide, 2% NP-40,
5% ampholines pH 3.5-10 [LKB] 9 M urea). The gels were run for 6 h at 500 V . After
a 2-h equilibration of these cylindrical gels with SDS-PAGE sample buffer (125 mM Tris-
HCI, 10% glycerol, 5% 2-ME, 2.3% SDS), they were applied to 12% SDS-PAGE gels for
electrophoresis in the second dimension. Gels were dried and autoradiography was carried
out at -70°C .
N-Glycanase andNeuraminidase Treatment.
￿
Removal of N-linked sugars was performed
using N-glycanase (Genzyme, Boston, MA) as described previously (6). For removal of
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FIGURE 1 .
￿
Comparison of the TCR-y/S expressed by a
panel of five hybridomas. Cells were surface iodinated
and, after lysis, the TCR-y/d-T3 complexes were isolated
by precipitation with theanti-T& mAb 2C11 . Duplicate
precipitations were carried out and one of these was
treated with N-glycanase to remove N-linked sugars. All
precipitates were analyzed on SDS-PAGE gels under re-
ducingconditions . (A) untreated, (B) N-glycanase treated .
y and 6 chains of. (1) DN12.1, (2) DN7.1, (3) DN7.3,
(4) 1C6.F11, and (5) 1H1 1 .B9 are shown .
sialic acid residues, immunoprecipitates were incubated for 16 h at 37°C with 0.1 U
neuraminidase (No. N5631 ; SigmaChemical Co., St . Louis, MO) in 50 mM sodium acetate
buffer, 0.9% NaCl, 0. I% CaC1 2, pH 5.5 .
Results and Discussion
Six TCR-7/6-expressing hybridomas (1C6.F11 and 1H11 .B9 of C3H/HeN
origin and DN12.1, DN7.1, DN7 .3, and DN2.3 of C57BL/6 origin) were used
in this study . Earlier studies (2, 6, 12, 13) have indicated that all these hybridomas
express glycosylated y chains that are not derived from Vy-Cy4 transcripts since
the antiserum used to detect these y chains does not react with Cy4 chains
(nomenclature according to Garman et al ., [10]) . Furthermore, since the Cy3
locus is a pseudogene (8) and, at least for the C57BL/6 mice, V71.2-C"y2
transcripts would result in nonglycosylated y chains (19), these hybridomas most
likely express y chains derived from Vy-CyI transcripts .
These hybridomas were 125I-labeled and subsequently lysed in digitonin buffer .
From these lysates the TCR-7/6-T3 complexes were isolated by immunoprecip-
itation with the anti-T& mAb 2C11 . The anti-T3 precipitates were digested
with N-glycanase, which specifically removes N-linked sugars, and these digested
samples and control, undigested samples were subsequently analyzed on SDS-
PAGE . The results (Fig . 1) indicate that the y chains of both C3H/HeN-derived
hybridomas (1C6.F11 and 1H11 .B9) have a slightly lower molecular weight
(both before and after removal of N-linked sugars) than the y chains of the
C57BL/6 derived hybridomas . A small but reproducible difference in the mo-
bility of the DN7.3 y chain versus the DN7.1 and DN12.1 y chains was also
observed (Fig . 1 ; data not shown) . The C57BL/6 derived hybridomas DN7.3
andDN2.3 expressed a S chain (glycosylated) with a lower molecular weight than
that of the S chains expressed by the other hybridomas (results shown for the
DN7.3 hybridoma only) . No clear differences in the molecular weights of
deglycosylated S chains could be observed .
Next, anti-T3 precipitates of the '251-labeled lysates were analyzed in more678
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FIGURE 2 . Two-dimensional
￿
gel
analysis (2-D NEPHGE/SDS-PAGE)
of TCR-y/S chains . Receptor com-
plexes were isolated by immunopre-
cipitation with theanti-T&mAb and
analyzed on two-dimensional
NEPHGE/SDS-PAGE as described
in Materialsand Methods . NEPHGE
was horizontal from right to left and
SDS-PAGE was vertical from top to
bottom . pH values indicated were
calculated from measurements in 1-
cm sections of a NEPHGE tube gel,
whichwasrun in parallel to the other
samples . Gels were aligned using the
loading point of the NEPHGE gels
and the T3 components as invariant
spots . In the case of panels D and E,
overexposed gels (not shown) were
used to verify the location of the T3
components. A non-neuraminidase-
treated sample was analyzed in A.
Samples in B-G were all neuramini-
dase treated . TCR chains from the
following hybridomas were analyzed :
(A and B) DN12 .1, (C) DN7.1, (D)
DN7.3, (E) DN2.3, (F) 1C6.F11,and
(G) IHII .B9 .
detail by two-dimensional NEPHGE/SDS-PAGE (Fig . 2) . To remove charge
heterogeneity due to sialic acid residues, duplicate precipitates were incubated
for 16 h at 37 °C with or without neuraminidase . Comparison ofa neuraminidase-
treated sample (Fig . 2B) with a non-neuraminidase-treated sample (Fig . 2A)
illustrates the effective reduction in charge heterogeneity by the removal of sialic
acids . With all .y and S chains analyzed in this panel, a shift to the basic side of
the gels was observed after neuraminidase treatment, indicating the presence of
sialic acid residues on all these -y and S chains (results before neuraminidase
treatment are shown for the DN12.1 TCR- ,y/S only) . To allow comparison of
the immunoprecipitates, the gels were aligned using the T3 components (as
shown in Fig . 2, A-C) and the loading point of the NEPHGE gels (not shown) as
invariant internal spots . The proper alignment of -y and 6 chains was crosschecked
in two additional experiments (not shown) . The results show that the y and S
chains oftwo C57BL/6-derived hybridomas (DN12.1 and DN7 .1, Fig . 2, B and
C) are indistinguishable by size and charge, and differ from those of both the
DN2 .3 and DN7.3 hybridomas (Fig . 2, D and E) . The S chains of the DN2 .3 and
DN7 .3 hybridomas are significantly different from each other (pH 7 .3 vs . pH
5 .9), whereas the .y chains are similar or identical . Thus the C57BL/6 hybridomas
express three distinguishable 6 chains and two distinguishable -y chains . Since theKONING ET AL.
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TABLE I
Characteristics ofy and S Chains Examined
* Since the y and d chains were analyzed by nonequilibrium pH gradient electrophoresis, the chains
do not run to their true isoelectric point. Therefore, the pH values given indicate only charge
differences between the various yand b chains anddo not represent pl values.
* Although the d,chains expressed by theC57BL/6and C3H/HeN hybridomas are indistinguishable,
it is not clear whether they are truly identical.
y chains from the C57BL/6 hybridomas are most likely derived from VT-Cyl
transcripts (see above), the difference in isoelectric points between these y chains
(DN2.3,DN7 .3: pH 7.7; DN7.1,DN12.1; pH 8.3) may reflect the useofdifferent
Vregions. They and 6 chains expressed by the independently derived C3H/HeN
hybridomas are indistinguishable by size and charge (Fig. 2, F and G). Further-
more, these chains are identical in charge to the y and S chains expressed by the
DN7.1 and DN12.1 hybridomas (Fig. 2, B and C).
To verify that the observed electrophoretic mobilities were due solely to
primary sequences, we examined the y and 6 chains for the presence ofpotential
charged prosthetic groups beside sialic acid. Essentially identical results to that
obtained with neuraminidase treatment alone were obtained when N-glycanaseR
or N-glycanaseR plus neuraminidase were used to remove charge due to the
presence ofcarbohydrate sidechains (not shown). This indicated thatsuch charge
heterogeneity was due entirely to the presence of sialic acid residues. To rule
out phosphorylation as a source ofcharge heterogeneity, we labeled with radio-
active phosphate. Neither the y nor d chains incorporated phosphate; however,
the Tae chain was labeled as expected (Pardoll, D. N., and D. Meuller, unpub-
lished observations). Also the y or S chains did not incorporate [35S]sulfate (not
shown) ruling out sulfation as a source ofheterogeneity.
The results presented in this study clearly indicate that, like ,y chains, multiple
forms of the S chain exist. Three distinct S chains could be identified that were
found to form four different y/S chain combinations with three distinct y chains
(Table I). Although three different TCR-y/d could be easily distinguished on
the four C57BL/6 thymus derived hybridomas (DN7.1, DN12.1, DN7.3, and
DN2.3), it is striking that the two independently derived hybridomas of
C3H/HeN origin (1C6 .F11 and 1H1 1.B9), which are both from the periphery
(skin), express an identical receptor. Also, the S chain expressed on the
C3H/HeN-derived hybridomas is indistinguishable in charge from that expressed
Strain
Molecular
Glycosylated
weight (x 10-')
Non-glycosy-
lated
Charge
(PH)*
Expressed
by with
C57BL/6 y, 35 32 8.3 DN12.1 S,*
DN 7.1 S,*
'rb 35 32.5 7.7 DN7.3 bb
DN2.3 S~
6,* 45 35 7.9 DN 12.1 y,
DN 7.1 ya
bb 44 35 7.3 DN 7.3 'rb
k 44 35 5.9 DN 2.3 'rb
C3H/HeN y, 34 31 8.3 1C6.F11 5,*
1H11 .89 S,*
E,t 45 35 7.9 1C6.FII y~
IHILB9 y~680
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on the C57BL/6-derived hybridomas DN7.1 and DN12.1 (Fig. 2, Table I) .
Therefore, although our results demonstrate that S chain diversity exists (three
different S chains detected), this diversity is apparently quite limited (four of six
hybridomas express an apparently identical b chain).
In conclusion, our results indicate that in addition to the y chains, the S chains
display diversity, even among hybridomas derived from a homozygous inbred
strain . This also indicates that the b chain could be encoded for by the recently
described TCR gene family, which is located within the a locus (14), a notion
that is also supported by the recent observation that putative human b cDNA
clones encode a protein that can be precipitated by an anti-6 mAb (20, 21) .
Moreover, the b chain diversity may significantly increase the polymorphic
potential of y/b receptors; however, further investigations will be needed to
clarify if this b chain diversity arises from the differential use of V, C, D, and/or
J-regions. Finally, screening of a larger panel of both thymus- and peripheral-
derived TCR-y/b expressing cells from one mouse strain will be needed to clarify
if thymus selection of, or thymus selection against certain TCR-y/b influences
the repertoire of TCR-7/6 expression in the periphery.
Summary
The TCR-y and -b chains of six murine hybridomas were compared by one-
dimensional SDS-PAGE and two-dimensional NEPHGE/SDS-PAGE analysis.
This allowed the identification of three distinct y chains (7,,, -Yb, and 7c) and
three distinct b chains (ba, bb, and &). Four y/b chain combinations ('Yaba, 'Ybbb,
1'bb,, and -ycba) were observed. These results indicate that multiple forms of the b
chain are expressed and suggest that the b chains are encoded for by an Ig-like
rearranging gene. This b chain polymorphism significantly enhances the potential
diversity of TCR-7/b, which may be of importance for a better understanding
of the putative ligand(s) recognized by this receptor.
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manuscript.
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